A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye Disease

NCT01664949 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

460

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Disease

Interventions

DRUG: Carboxymethylcellulose Based Eye Drop Formulation A
DRUG: Carboxymethylcellulose Based Preservative-Free Lubricant Eye Drops

Sponsor

Allergan